AliveDx Suisse S.A. and Vital Care Prod SPA have signed a distribution agreement, which will enable Vital Care to distribute the MosaiQ® and LumiQ™ solutions in Algeria. The distribution agreement takes effect immediately.
This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding in faster diagnosis. This collaboration will allow both parties to launch new quality services in the healthcare industry and improve patient care in Algeria.
The combination of the MosaiQ and LumiQ platforms simplifies workflows and enhances efficiency through advanced multiplexing microarray assay technology. This streamlined approach delivers faster, more cost-effective solutions, benefiting both healthcare providers and patients.
“This is another great opportunity to highlight AliveDx’s dedication to transforming patient care worldwide and strengthening the healthcare system with fast and innovative diagnostic solutions,” said Manuel O. Méndez, AliveDx’s CEO.
Vital Care Production, Distribution & Logistics is a major manufacturer of medical devices in Algeria since 2016. The company employs over 355 people, mainly in industrial operations, and sales & marketing. Vital Care provides high quality medical devices and solutions that meet the specific needs of patients, improving their life quality.
“I am very excited to launch the Vital care Diagnostic division with our partner AliveDx Suisse S.A. This is the first achievement in our ambition to provide healthcare professionals with a full range of premium and innovative diagnostic solutions that enable them to make precise and relevant medical decisions. The power of diagnostic data is transforming the way our society manages healthcare,” said Zoubir Tabloul, Vital Care’s CEO.
To learn more, please visit the Vital Care website.
